Clinical risk factors of bevacizumab-related hypertension in patients with metastatic colorectal cancer: a retrospective study.

Front Pharmacol · 2024 · PMC11543948 · PMID 39525635

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

a trend toward significanceP = 0.10so close (0.05 < p ≤ 0.1)

Although irinotecan co-administration was not significantly associated with bevacizumab-related hypertension, it showed a trend toward significance (OR = 0.58, P = 0.10).

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.